Reticulate scleroderma after isolated limb perfusion with melphalan

Journal of the American Academy of Dermatology

Volumn 39, Issue 6, 1998, Pages 1011-1012

  Landau, M ^a   Brenner, S ^a   Gat, A ^a   Klausner, J M ^a   Gutman, M ^a  

^a TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

MELPHALAN; RECOMBINANT TUMOR NECROSIS FACTOR ALPHA;

ADJUVANT THERAPY; ADULT; ADVANCED CANCER; ANTIBIOTIC THERAPY; ARTICLE; BLISTER; CASE REPORT; CLINICAL FEATURE; CORTICOSTEROID THERAPY; ERYTHEMA; HUMAN; LIMB PERFUSION; LUNG FIBROSIS; MALE; MELANOMA; NEUROPATHY; PRIORITY JOURNAL; SCLERODERMA; SKIN MANIFESTATION; SOFT TISSUE SARCOMA;

EID: 0031733638     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0190-9622(98)70279-8     Document Type: Article

References (9)

1. ET Krementz RF Ryan JH Muchmore RD Carter CM Sutherland RJ Reed Hyperthermic regional perfusion for melanoma of the limbs 2nd ed CM Balch AN Houghton GW Milton AJ Sober SJ Soong Cutaneous melanoma 1992 JB Lippincott Philadelphia 403 422
2. O Creech Jr ET Krementz RF Ryan JW Winblad Chemotherapy of cancer: regional perfusion utilizing an extracorporeal circuit Ann Surg 148 1958 616 632
3. D Lienard P Ewalenko JJ Delmotte N Renard FJ Lejeune High dose recombinant tumor necrosis factor alpha in combination with interferon gamma and melphalan in isolation perfusion of the limbs for melanoma and sarcoma J Clin Oncol 10 1992 52 60
4. DL Bartlett G Ma HR Alexander SK Libutti DL Fraker Isolated limb reperfusion with tumor necrosis factor and melphalan in patients with extremity melanoma after failure of isolated limb perfusion with chemotherapeutics Cancer 80 1997 2084 2090
5. P Sorkin S Abu-Abid D Lev M Gutman D Aderka P Halpern Systemic leakage and side effects of tumor necrosis factor administered via isolated limb perfusion can be manipulated by flow rate adjustment Arch Surg 130 1995 1079 1084
6. BC Vrouenraets BBR Kroon JM Klaase OE Nieweg GW van Slooten JA van Dongen Severe acute regional toxicity after normothermic or “mild” hyperthermic isolated limb perfusion with melphalan for melanoma Melanoma Res 5 1995 425 431
7. M Gutman M Inbar D Lev-Shlush S Abu-Abid M Mozes S Chatchik High dose tumor necrosis factor-α and melphalan administered via isolated limb perfusion for advanced limb soft tissue sarcoma results in a 90% response rate and limb preservation Cancer 79 1997 1129 1137
8. R Taetle PS Dickman PS Feldman Pulmonary histopathological changes associated with melphalan therapy Cancer 42 1978 1239 1245
9. H Takeda A Hatamochi M Arakawa H Ueki Effects of tumor necrosis factor-alpha on connective tissue metabolism in normal and scleroderma fibroblast cultures Arch Dermatol Res 284 1993 440 444